A transistor-type sensor capable of detecting a compound having an amino group has a simple structure and also is expected to be effective in antioxidation action and prevention of dementia, etc. The transistor-type sensor includes a detection electrode for capturing a compound having an amino group for detection, and a transistor having a gate electrode connected with the detection electrode. The detection electrode has a cucurbituril structure-containing compound immobilized on the surface thereof.

A transistor-type sensor capable of detecting a compound having an amino group has a simple structure and also is expected to be effective in antioxidation action and prevention of dementia, etc. The transistor-type sensor includes a detection electrode for capturing a compound having an amino group for detection, and a transistor having a gate electrode connected with the detection electrode. The detection electrode has a cucurbituril structure-containing compound immobilized on the surface thereof.

A micromechanical sensor comprising a nucleic acid or nucleic acid analog nanostructure, such as a DNA origami or tiled structure, sensor spring and fluorophores arranged in FRET pairs in the sensor spring is provided, as well as methods of using the micromechanical sensor.

A micromechanical sensor comprising a nucleic acid or nucleic acid analog nanostructure, such as a DNA origami or tiled structure, sensor spring and fluorophores arranged in FRET pairs in the sensor spring is provided, as well as methods of using the micromechanical sensor.

In one aspect, the present disclosure provides organic semiconductors (OSNTs) as well as high-performance electrochemical devices based on the present OSNTs for the production of micro and nano-scale actuators. The present OSNTs may be used in several applications, including movable and implantable interface devices, such as flexible neural microelectrodes. Also provided herein are flexible neural microelectrodes based on conjugated polymer actuators

In one aspect, the present disclosure provides organic semiconductors (OSNTs) as well as high-performance electrochemical devices based on the present OSNTs for the production of micro and nano-scale actuators. The present OSNTs may be used in several applications, including movable and implantable interface devices, such as flexible neural microelectrodes. Also provided herein are flexible neural microelectrodes based on conjugated polymer actuators

The present disclosure relates to methods of writing data in nucleic acid chains and methods of reading data written in nucleic acid chains. The present disclosure also relates to a kit for writing and reading data in nucleic acid chains.

The present invention teaches multiple three-dimensional nanosensing geometries for simultaneously assaying both large and small bio-related molecules in one device. The invention delivers broader sensitivity and selectivity than devices that assay small or large molecules separately. The combination assays all classes of molecules, e.g., proteins, lipoproteins, nucleoproteins, lipids, phospholipids, carbohydrates, nucleic acids, simple sugars, hormones, volatile organic compounds, drugs, drug metabolites, etc. Broad collection enables i) rapid and accurate diagnosis, ii) likely courses of treatments, and iii) timely feedback that monitors and follows the progressions of treatment(s). In one example, a patient's pattern of blood lipids, proteins—including proteins with alternate cleavage patterns, peptides—including endocrine peptides, thyroxine (and/or other hormones), and drug metabolites, forms a profile specific to that patient at that time. The profile is inputted for analysis by comparing it to a library of pooled data. Applying artificial intelligence (AI) to this comparison allows accurate diagnosis and then can suggest historically validated treatments most suited to that patient.

The present invention teaches multiple three-dimensional nanosensing geometries for simultaneously assaying both large and small bio-related molecules in one device. The invention delivers broader sensitivity and selectivity than devices that assay small or large molecules separately. The combination assays all classes of molecules, e.g., proteins, lipoproteins, nucleoproteins, lipids, phospholipids, carbohydrates, nucleic acids, simple sugars, hormones, volatile organic compounds, drugs, drug metabolites, etc. Broad collection enables i) rapid and accurate diagnosis, ii) likely courses of treatments, and iii) timely feedback that monitors and follows the progressions of treatment(s). In one example, a patient's pattern of blood lipids, proteins—including proteins with alternate cleavage patterns, peptides—including endocrine peptides, thyroxine (and/or other hormones), and drug metabolites, forms a profile specific to that patient at that time. The profile is inputted for analysis by comparing it to a library of pooled data. Applying artificial intelligence (AI) to this comparison allows accurate diagnosis and then can suggest historically validated treatments most suited to that patient.

Described herein are nanoprobes comprising ultrasmall aminated and cRGDY-conjugated nanoparticles labeled with Zirconium-89 (.sup.89Zr) and methods of their use. The provided compositions are renally clearable and possess suitable blood circulation half-time, high tumor active targeting capability, dominant renal clearance, low liver accumulation, and a high tumor-to-background ratio. The described nanoprobes exhibit great potential as “target-or-clear” tracers to human subjects for systemic targeted imaging (or treatment) of cancer.